human
serum
albumin
hsa
fig
abund
plasma
carrier
protein
human
respons
transport
mani
endogen
exogen
agent
drug
bind
abil
hsa
directli
relat
effect
clinic
therapi
due
strongli
influenc
free
drug
concentr
plasma
therefor
drugbind
abil
toward
hsa
crucial
factor
care
consid
drug
research
bovin
serum
albumin
bsa
fig
excel
structur
similar
hsa
repeat
pattern
disulphid
bond
studi
extens
replac
hsa
due
easi
access
high
stabil
danhong
inject
dhi
chines
materia
medica
standard
product
extract
danshen
radix
salvia
miltiorrhiza
honghua
flo
carthami
tinctorii
dhi
mainli
use
clinic
treat
ischem
encephalopathi
coronari
heart
diseas
due
abil
promot
blood
circul
resolv
stasi
promot
regener
previou
studi
demonstr
salvianol
acid
danshen
radix
salvia
miltiorrhiza
nucleosid
flavonoid
phenylethanoid
glycosid
honghua
flo
carthami
tinctorii
might
potent
activ
compon
therapeut
effect
dhi
vitro
experi
identifi
natur
compon
bind
hsa
bsa
mani
compon
still
need
care
studi
studi
carri
rel
pure
condit
ignor
complex
condit
natur
product
exist
plant
inde
dhi
varieti
main
compon
coexist
togeth
affect
interact
singl
compon
serum
albumin
therefor
investig
activ
compon
fig
bind
abil
bsa
discuss
influenc
serum
albumin
bind
compon
coexist
would
provid
meaning
insight
transport
distribut
metabol
dhi
new
perspect
reveal
compat
principl
dhi
fluoresc
spectroscopi
technolog
wide
use
investig
interact
drug
protein
system
gener
fluoresc
spectrum
bsa
domin
tryptophan
residu
fig
high
sensit
two
tryptophan
residu
local
environ
use
intrins
tryptophan
fluoresc
probe
studi
interact
natur
compon
dhi
serum
protein
molecular
dock
import
techniqu
computeraid
drug
design
cadd
techniqu
could
provid
detail
orient
proteindrug
system
includ
bind
mode
structur
conform
drug
molecul
paper
bind
activ
compon
bsa
subsequ
investig
fluoresc
techniqu
bind
paramet
ka
kb
ksv
kqand
n
thu
determin
molecular
dock
compon
bsahsa
discuss
use
autodock
vina
softwar
identifi
bind
site
compound
moreov
explor
influenc
multicompon
coexist
dhi
interact
singl
compon
bsa
bovin
serum
albumin
bsa
obtain
solarbio
china
use
without
purif
salvianol
acid
b
sab
adenosin
ade
cytidin
cyt
uridin
uri
phenylalanin
phe
warfarin
war
ibuprofen
ibu
obtain
nation
institut
food
drug
control
beij
china
hydroxysafflor
yellow
hsya
syringin
syr
danshensu
dss
purchas
zhongxin
innova
laboratori
tianjin
china
sabfre
dhi
sampl
obtain
wuxi
apptec
tianjin
co
ltd
chemic
use
suppli
without
purif
bsa
stock
solut
mm
prepar
physiolog
aqueou
solut
mm
phosphat
buffer
ph
stock
solut
warfarin
mm
prepar
methanol
prepar
ibuprofen
test
compon
stock
solut
mm
similar
bsa
stock
solut
stock
solut
kept
dark
fluorometr
experi
record
multifunct
micropl
reader
perkinelm
corpor
usa
stock
solut
bsa
test
compon
dilut
requir
experiment
sampl
concentr
mix
multipl
colorimetr
tube
sab
syr
rang
concentr
hsyr
rang
concentr
dss
cyt
uri
ade
phe
rang
concentr
test
solut
fluoresc
spectroscopi
prepar
differ
concentr
via
stepwis
dilut
avoid
inner
filter
effect
use
dilut
solut
experi
ensur
final
concentr
bsa
test
solut
incub
k
min
transfer
black
fluoromicropl
corn
usa
fluoresc
spectroscopi
test
carri
temperatur
simul
bodi
temperatur
excit
wavelength
nm
emiss
spectra
record
nm
maximum
emiss
intens
use
calcul
bind
paramet
order
correct
background
appropri
blank
subtract
accord
seri
preliminari
experi
threedimension
crystal
structur
bsa
entri
code
hsa
complex
warfarin
entri
code
ibuprofen
entri
code
obtain
protein
data
bank
pdb
two
dimension
structur
test
compon
drawn
use
chembiodraw
ultra
convert
threedimension
structur
chembio
ultra
initi
threedimension
structur
optim
use
forc
field
default
paramet
auto
dock
tool
adt
soft
use
convert
file
final
coordin
file
dock
studi
molecular
dock
simul
compound
perform
autodock
vina
program
comput
perform
use
default
paramet
describ
autodock
vina
manual
except
grid
dimens
consid
differ
molecul
size
grid
comput
perform
larg
possibl
grid
box
space
ensur
enough
box
dimens
cover
activ
site
residu
allow
flexibl
rotat
molecul
grid
center
middl
sudlow
site
sudlow
site
ii
respect
dock
result
shown
pymol
bind
test
natur
compon
would
caus
differ
chang
fluoresc
spectra
bsa
due
protein
conform
transform
interact
test
compon
bsa
studi
analysi
fluoresc
spectra
bsa
absenc
presenc
differ
concentr
test
compon
effect
compon
bsa
fluoresc
spectra
shown
fig
shown
fig
excit
wavelength
fix
nm
bsa
strong
fluoresc
emiss
band
nm
decreas
fluoresc
intens
valu
bsa
nm
follow
success
addit
sab
hsya
indic
two
compon
could
quench
fluoresc
bsa
meanwhil
increas
fluoresc
intens
valu
bsa
nm
follow
success
addit
syr
indic
syr
could
enhanc
fluoresc
bsa
result
suggest
sab
hsya
syr
could
bind
bsa
induc
microenviron
transform
around
bsa
protein
peak
posit
fluoresc
emiss
spectra
maintain
nm
without
blue
shift
red
shift
suggest
bind
three
natur
compon
caus
obviou
chang
polar
environ
around
chromophor
tryptophan
quench
effici
sab
much
greater
hsya
concentr
subsequ
addit
sab
increas
emiss
nm
due
sab
bound
bsa
addit
occurr
isoactin
point
nm
consid
direct
evid
exist
sabbsa
complex
suggest
static
quench
process
sabbsa
bind
system
beyond
three
compon
obviou
chang
fluoresc
spectra
bsa
success
addit
five
compon
possibl
due
low
bind
five
compon
bsa
lead
littl
chang
microenviron
around
chromophor
tryptophan
illustr
bind
profil
test
compon
fluoresc
emiss
intens
data
bsa
peak
posit
analyz
follow
equat
eq
eq
shown
fig
accord
fluoresc
spectrometri
studi
sab
hsya
quench
intrins
fluoresc
bsa
quantum
yield
fluoresc
decreas
increas
quencher
molecul
concentr
fluoresc
quench
divid
static
quench
procedur
dynam
quench
procedur
static
quench
usual
result
format
stabl
complex
protein
quencher
dynam
quench
usual
result
collision
encount
protein
quencher
static
dynam
quench
procedur
describ
use
linear
sternvolm
equat
follow
shown
fig
curv
versu
q
good
linear
ratio
csabcbsa
rang
ratio
chysacbsa
rang
plot
accord
eq
ratio
csabcbsa
larger
sternvolm
plot
sabbsa
system
chang
upward
curvatur
indic
combin
quench
procedur
higher
concentr
ratio
csabcbsa
modifi
sternvolm
equat
eq
anoth
way
describ
quench
process
modifi
sternvolm
plot
sabbsa
system
hysabsa
system
shown
fig
fluoresc
emiss
intens
bsa
also
analyz
modifi
scatchard
equat
follow
log
f
logkbnlogq
though
modifi
scatchard
equat
log
f
plot
log
q
valu
kb
n
found
intercept
slope
respect
shown
fig
howev
intens
bsa
intrins
fluoresc
increas
increas
syr
concentr
condit
fluoresc
data
analyz
lineweaverburk
equat
follow
result
shown
fig
calcul
fluoresc
paramet
singl
compon
bind
bsa
present
tabl
studi
bind
paramet
kq
sab
calcul
sternvolm
eq
much
larger
hsya
two
calcul
kq
valu
far
higher
maximum
scatter
collis
quench
constant
indic
quench
process
sab
hsya
bsa
initi
static
quench
mechan
result
confirm
analysi
fluoresc
emiss
spectrometri
bind
paramet
ka
obtain
eq
sab
hsya
respect
valu
kb
n
sab
hsya
also
calcul
plot
log
f
log
q
bind
constant
kb
sab
still
larger
hsya
valu
n
sab
hsya
respect
therefor
prove
one
class
bind
site
sab
hsya
bsa
paramet
sab
consist
previou
studi
base
data
conclud
sabbsa
bind
stronger
bind
hsyabsa
due
much
higher
valu
ksv
kq
kb
fluoresc
enhanc
situat
fluoresc
data
syr
analyz
use
eq
bind
constant
k
syrbsa
system
base
studi
sab
highli
bound
serum
albumin
mean
compar
overal
amount
sab
amount
sab
avail
diffus
target
tissu
may
significantli
reduc
pharmacolog
effect
may
consequ
poor
howev
multicompon
coexist
dhi
would
inde
affect
bind
sabserum
albumin
system
therebi
chang
free
sab
concentr
plasma
therefor
influenc
coexist
multicompon
sabserum
albumin
bind
care
studi
determin
scientif
principl
compat
tradit
chines
medicin
ensur
safeti
clinic
applic
site
marker
competit
experi
carri
identifi
bind
site
sab
bsa
use
molecul
well
known
specif
bind
marker
bsa
bsa
globular
heartshap
nonglycoprotein
two
ligandbind
site
locat
hydrophob
caviti
refer
sudlow
site
site
ii
xray
crystallograph
studi
warfarin
demonstr
site
marker
site
hsa
ibuprofen
site
ii
binder
due
sequenc
ident
bsa
hsa
warfarin
ibuprofen
still
use
site
marker
site
site
ii
bsa
respect
even
exact
xray
crystal
structur
warfarinbsa
complex
ibuprofenbsa
complex
thu
inform
sab
bind
site
obtain
compar
differ
fluoresc
sabbsa
bind
system
absenc
presenc
two
marker
site
marker
competit
experi
bsa
rel
site
marker
mix
ratio
differ
concentr
sab
solut
prepar
fluoresc
quench
data
sabbsa
system
presenc
site
marker
analyz
use
eq
eq
shown
fig
bind
paramet
calcul
summar
tabl
bind
paramet
sabbsa
system
warfarin
decreas
almost
compar
without
warfarin
hand
bind
paramet
sabbsa
system
without
ibuprofen
compar
result
suggest
sab
bound
bsa
within
sudlow
site
posit
order
discuss
effect
coexist
compon
honghua
flo
carthami
tinctorii
dhi
sabbsa
bind
system
carri
seri
fluoresc
spectrometri
studi
sabbsa
bind
system
presenc
compon
first
bsa
mix
coexist
compon
ratio
test
solut
contain
differ
concentr
sab
prepar
fix
bsa
coexist
compon
concentr
shown
fig
tabl
sab
also
caus
intrins
fluoresc
quench
bsa
presenc
hysa
syr
phe
uri
cyt
ade
presenc
natur
compon
still
upward
curvatur
concentr
larger
within
linear
concentr
valu
kq
sabbsa
system
still
larger
result
suggest
coexist
chang
quench
mechan
sabbsa
bind
system
shown
tabl
hysa
syr
uri
cyt
ade
decreas
bind
paramet
kb
sabbsa
system
phe
enhanc
bind
paramet
kb
sabbsa
system
chang
bind
paramet
kq
ksv
ka
similar
kb
therefor
particip
natur
compon
may
affect
interact
sabbsa
system
furthermor
verifi
interact
sab
bsa
entir
dhi
system
collabor
prepar
special
sampl
dhi
specif
knockedout
sab
experi
concentr
bsa
sfdhi
respect
concentr
sab
vari
shown
fig
tabl
fluoresc
emiss
spectra
bsa
differ
concentr
sab
presenc
sfdhi
similar
absenc
sfdhi
concentr
curv
versu
q
linear
concentr
greater
sternvolm
plot
chang
upward
curvatur
indic
combin
quench
higher
concentr
ratio
csabcbsa
valu
kq
sab
still
greater
indic
quench
also
correspond
static
quench
mechan
paramet
also
calcul
within
linear
concentr
summar
tabl
compar
bind
paramet
kb
pure
sabbsa
system
sfdhi
decreas
bind
paramet
kb
sabbsa
system
chang
bind
paramet
kq
ksv
ka
agre
kb
base
studi
dhi
use
mammal
bodi
sab
releas
serum
albumin
quickli
use
alon
may
increas
concentr
unbound
sab
plasma
improv
pharmacolog
effect
sab
autodock
vinabas
molecular
dock
includ
entir
surfac
search
select
protein
region
locateth
optimum
bind
site
energi
match
calcul
identifi
conform
ligand
molecul
aim
studi
evalu
bind
affin
compon
dhi
plasma
protein
determin
optimum
bind
site
two
crystallograph
structur
hsa
cocrystal
warfarin
entri
code
ibuprofen
entri
code
protein
data
bank
pdb
select
dock
studi
warfarin
ibuprofen
demonstr
site
marker
site
site
ii
conform
protein
site
marker
good
start
model
dock
studi
hand
structur
inform
bsa
proper
site
marker
ligand
warfarin
ibuprofen
provid
protein
data
bank
chose
crystallograph
structur
encod
dock
studi
toward
bsa
crystallograph
structur
provid
inform
amio
acid
residu
lie
site
bind
pocket
presenc
ligand
moreov
cocrystal
ligand
locat
site
site
ii
bind
pocket
also
use
simul
amio
acid
residu
lie
site
ii
bind
pocket
dock
score
present
tabl
molecular
dock
data
could
confer
ade
phe
dss
uri
cyt
bound
weakli
bsa
hsa
hsya
syr
much
higher
bind
abil
bsa
hsa
sab
repres
highest
bind
abil
bsa
hsa
meanwhil
bind
site
sab
hsya
syr
within
sudlow
site
dock
result
offer
ration
molecular
explan
previou
experiment
find
evid
sever
amino
acid
hydrophob
hydrophil
characterist
contact
sab
bsa
hsa
complex
hydrogen
bond
play
import
role
bind
system
sabbsa
complex
sab
surround
bind
energi
kcalmol
fig
form
hydrogen
bond
sab
sabhsa
complex
sab
locat
near
bind
energi
kcalmol
fig
form
hydrogen
bond
sab
water
molecul
also
like
serv
bridg
produc
hydrogen
bond
studi
interact
natur
compon
dhi
bsa
physiolog
condit
investig
use
fluoresc
spectra
technolog
molecular
dock
studi
compon
bsahsa
carri
provid
molecular
explan
bind
system
accord
result
sab
exhibit
strong
abil
quench
intrins
fluoresc
bsa
static
quench
procedur
bind
constant
kb
k
hysa
show
much
lower
bind
abil
bind
constant
kb
k
syr
could
enhanc
intrins
fluoresc
bsa
bind
constant
k
k
base
studi
chose
sab
research
target
investig
influenc
multicompon
coexist
dhi
serum
albumin
bind
result
show
particip
natur
compon
dhi
could
affect
interact
sabbsa
system
therefor
conclud
dhi
use
mammal
sab
would
releas
serum
albumin
quickli
may
increas
concentr
unbound
sab
plasma
improv
pharmacolog
effect
sab
work
provid
research
basi
ration
clinic
use
dhi
also
provid
new
perspect
reveal
compat
principl
dhi
